Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rashmi Sharma
Observed name:
Rashmi sharma
Institution:
Indian Institute of Technology Delhi
Observed institution:
Indian Institute of Technology Delhi
ORCID:
0000-0002-6041-952X
Observed ORCID:
0000-0002-6041-952X
OpenAlex ID:
A5080039532
Optimization of the in-vitro refolding of biotherapeutic Fab Ranibizumab
2022
·
Rashmi Sharma
, Anupa Anupa
, et al.
·
Biochemical Engineering Journal
·
14
Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies
2026
·
Anurag S. Rathore
, Subhankar Metya
, et al.
·
Advanced Drug Delivery Reviews
·
12
Process optimization using machine learning enhanced design of experiments (DOE): ranibizumab refolding as a case study
2022
·
Saxena Nikita
, Rashmi Sharma
, et al.
·
Reaction Chemistry & Engineering
·
11
Disassembly mediated multimodal chromatography based purification of HPV-VLPs produced in Pichia pastoris
2025
·
Rashmi Sharma
, Pragya Prakash
, et al.
·
Journal of Virological Methods
·
9
Application of ensemble learning to augment fluorescence-based PAT and enable real-time monitoring of protein refolding
2024
·
Rashmi Sharma
, Naveen G. Jesubalan
, et al.
·
Biochemical Engineering Journal
·
8
Refolding of Proteins Expressed as Inclusion Bodies in E. coli
2023
·
Rashmi Sharma
, Anupa Anupa
, et al.
·
Methods in molecular biology
·
6
Novel purification platform based on multimodal preparative scale separation of mAb fragments and aggregates
2024
·
Rashmi Sharma
, Surbhi Gupta
, et al.
·
Journal of Chromatography A
·
5
Integrating Ensemble NSGA‐II for Multi‐Objective Process Optimization: Refolding of Proinsulin as a Case Study
2025
·
Rashmi Sharma
, Naveen G. Jesubalan
, et al.
·
Biotechnology and Bioengineering
·
1
PDF
MOO ‐based implementation of process analytical technology framework: Protein refolding as a case study
2026
·
Naveen G. Jesubalan
, Rashmi Sharma
, et al.
·
AIChE Journal
Integrated continuous purification for antigen-binding fragments (Fab) expressed as inclusion bodies: Ranibizumab as a case study
2022
·
Anupa ANUPA
, Nikhil Kateja
, et al.
Show more works
View as search
Works count:
10
Citation count:
66
H-index:
6
I10-index:
3
Year
Topic
Type